Teleflex | TFX - Selling And Administration Expenses



Teleflex reported $215.08M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Abbott USD 3.09B 39M Jun/2025
Align Technology USD 448.69M 1.06M Jun/2025
AtriCure USD 78.39M 2.34M Jun/2025
Avanos Medical USD 83.5M 7.8M Jun/2025
Baxter International USD 718M 15M Jun/2025
Becton, Dickinson and Co. USD 1.32B 47M Jun/2025
Boston Scientific USD 1.72B 119M Jun/2025
Cooper Companies USD 421.7M 22.7M Jul/2025
Dexcom USD 328M 17.9M Jun/2025
Edwards Lifesciences USD 502M 36.3M Jun/2025
General Electric Aerospace USD 1.02B 144M Jun/2025
Globus Medical USD 303.62M 60.82M Jun/2025
Haemonetics USD 91.24M 23.89M Jun/2025
Hologic USD 251.3M 15.1M Jun/2025
Insulet USD 253.3M 7.3M Jun/2025
Integra LifeSciences USD 179.89M 15.88M Jun/2025
Intuitive Surgical USD 561.2M 2.2M Jun/2025
J&J USD 5.89B 777M Jun/2025
Masimo USD 138.9M 19.5M Jun/2025
Medtronic USD 2.81B 106M Jul/2025
Merit Medical Systems USD 113.1M 5.61M Jun/2025
ResMed USD 265.12M 19.82M Jun/2025
Steris USD 353.8M 19.9M Jun/2025
Stryker USD 2.08B 221M Jun/2025
Tandem Diabetes Care USD 93.05M 11.91M Jun/2025
Teleflex USD 215.08M 7.63M Jun/2025
Zimmer Biomet Holdings USD 814.8M 56M Jun/2025